Clinical Trial Update: Trial of 2 Step ATG for Prevention of Acute GVHD Post Allogeneic Stem Cell Transplant [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial from University of Alabama at Birmingham evaluating a two-step anti-thymocyte globulin regimen to prevent acute graft-versus-host disea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes
• Myeloproliferative Neoplasms

Drugs mentioned

• Anti-thymocyte globulin (ATG) (anti-thymocyte globulin)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Acute Leukemia, Myelodysplastic Syndrome | Phase 2 | Status: RECRUITING